MedTrace Logo

A Post Marking Study to Evaluate the Safety of FluMist in Children

NCT00569894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29296

Last updated 2012-03-08

No results posted yet for this study

Summary

To assess the safety of FluMist vaccination

Conditions

  • Healthy

Interventions

BIOLOGICAL

FLuMist

One or two vaccinations with FluMist depending on prior vaccination status.

BIOLOGICAL

TIV (Injection)

One or two injections of TIV depending on previous status.

OTHER

Unvaccinated Control

no vaccine

Sponsors & Collaborators

  • MedImmune LLC

    lead INDUSTRY

Principal Investigators

  • Seth Toback, M.D. · MedImmune LLC

Eligibility

Min Age
24 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00569894 on ClinicalTrials.gov